• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

HLA-DQB2 cDNA Clone – Major Histocompatibility Complex, Class II, Dq Beta 2 (Human)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS1265733

MBS1265733 is a cDNA clone targeting HLA-DQB2. More details

$235 / 0.01 mg Plasmid + 0.2 mL Glycerol-Stock +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
HLA-DQB2, cDNA Clone
Full Product Name
HLA-DQB2 cDNA Clone
Product Gene Name
Sequence
ATGTCTTGGA AGATGGCTCT GCAGATCCCT GGAGGCTTTT GGGCAGCAGC TGTGACCGTG ATGCTGGTGA TGCTGAGCAC CCCAGTGGCT GAGGCCAGAG ACTTTCCCAA GGATTTCTTG GTCCAGTTTA AGGGCATGTG CTACTTCACC AACGGGACAG AGCGCGTGCG GGGTGTGGCC AGATACATCT ATAACCGCGA GGAGTACGGG CGCTTCGACA GCGACGTTGG GGAGTTCCAG GCGGTGACCG AGCTGGGGCG GAGCATCGAG GACTGGAACA ACTATAAGGA CTTCTTGGAG CAGGAGCGGG CCGCGGTGGA CAAGGTGTGC AGACACAACT ACGAGGCGGA GCTACGCACG ACCTTGCAGC GGCAAGTGGA GCCCACAGTG ACCATCTCCC CATCCAGGAC AGAGGCCCTC AACCACCACA ACCTGCTGGT CTGCTCAGTG ACAGATTTCT ATCCAGCCCA GATCAAAGTC CAGTGGTTTC GGAATGACCA GGAGGAGACA GCCGGTGTTG TGTCCACCTC CCTCATTAGG AATGGTGACT GGACCTTCCA GATTCTGGTG ATGCTGGAAA TAACTCCCCA GCGTGGAGAC ATCTACACCT GCCAAGTGGA GCACCCCAGC CTCCAGAGCC CCATCACCGT GGAGTGGCGA CCTCGAGGGC CTCCACCTGC AGGACTCCTG CACTGA
OMIM
615161
cDNA Size
696 bp
Definition
Homo sapiens major histocompatibility complex, class II, DQ beta 2,mRNA (cDNA clone IMAGE: 4747201).
Recombination site
attL1, attL2
Vector
pENTR223.1 (spectinomycin)
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.

Other Notes

Small volumes of HLA-DQB2 cdna clone vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for HLA-DQB2. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Secondary Accession #
UniProt Related Accession #
NCBI Official Full Name
Homo sapiens major histocompatibility complex, class II, DQ beta 2, mRNA
NCBI Official Synonym Full Names
major histocompatibility complex, class II, DQ beta 2
NCBI Official Symbol
HLA-DQB2
NCBI Official Synonym Symbols
HLA-DXB; HLA-DQB1
UniProt Protein Name
HLA class II histocompatibility antigen, DQ beta 2 chain
UniProt Synonym Protein Names
HLA class II histocompatibility antigen, DX beta chain; MHC class II antigen DQB2
UniProt Gene Name
HLA-DQB2
UniProt Synonym Gene Names
HLA-DXB
UniProt Entry Name
DQB2_HUMAN
NCBI Protein Information
HLA class II histocompatibility antigen, DQ beta 2 chain

NCBI Summary for HLA-DQB2

HLA-DQB2 belongs to the family of HLA class II beta chain paralogs. Class II molecules are heterodimers consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. They play a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). Polymorphisms in the alpha and beta chains specify the peptide binding specificity, and typing for these polymorphisms is routinely done for bone marrow transplantation. However this gene, HLA-DQB2, is not routinely typed, as it is not thought to have an effect on transplantation. There is conflicting evidence in the literature and public sequence databases for the protein-coding capacity of HLA-DQB2. Because there is evidence of transcription and an intact ORF, HLA-DQB2 is represented in Entrez Gene and in RefSeq as a protein-coding locus. [provided by RefSeq, Oct 2010]
Show more

UniProt Comments for HLA-DQB2

HLA-DQB2: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading. Belongs to the MHC class II family. Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. Dimer formation with HLA-DQA2, but not with HLA-DQA1, is required for efficient exit from the endoplasmic reticulum (ER). In the ER, forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariant chain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoes sequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHC class II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding of antigenic peptides. Association with HLA-DMA also occurs in skin Langerhans cells, in post-Golgi compartments. 2 isoforms of the human protein are produced by alternative splicing

Chromosomal Location of Human Ortholog: 6p21

Cellular Component: Golgi membrane; lysosomal membrane; plasma membrane; trans-Golgi network membrane

Biological Process: antigen processing and presentation of exogenous peptide antigen via MHC class II; T cell costimulation; T cell receptor signaling pathway
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Organs/Tissues associated with HLA-DQB2 cdna clone

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000